Albemarle Corporation Home
Albemarle Albemarle
Albemarle
    • August 30, 2010

    • Albemarle Names Karen G. Narwold Senior Vice President and General Counsel
    • August 30, 2010

    • Albemarle Increases Prices of FCC Catalysts and Implements Rare Earth Surcharges on FCC Catalysts and Additives
    • August 23, 2010

    • Albemarle to Increase Prices of SAYTEX(R) Brominated Flame Retardants
    • August 19, 2010

    • Albemarle to Increase Prices of MARTINAL(R) Mineral Flame Retardants

Albemarle to Increase Prices of ETHACURE(R) Curatives
line

BATON ROUGE, La., Aug. 19 /PRNewswire-FirstCall/ -- Specialty chemicals maker Albemarle Corporation (NYSE: ALB), a leading global manufacturer of liquid curing agents for epoxy, polyurethane and polyurea systems for coatings, reaction-injection-molded (RIM) parts and other applications, will increase the prices of select ETHACURE curatives worldwide effective September 1, 2008, or as contracts allow.

The prices of ETHACURE 100 and ETHACURE 100 LC curatives will increase by $0.35/lb worldwide. The price of ETHACURE 300 curative will increase by $0.30/lb worldwide.

ETHACURE curatives are manufactured in the U.S.A., and are part of Albemarle's Polymer Additives business segment. For more information about ETHACURE curatives, visit http://www.ethacure.com.

Albemarle Corporation, headquartered in Baton Rouge, La., is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics; petroleum and petrochemical processing; transportation and industrial products; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments -- Polymer Additives, Catalysts and Fine Chemicals -- serves customers in approximately 100 countries. Learn more about Albemarle at http://www.albemarle.com.

Forward-Looking Statements:

Portions of this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although Albemarle Corporation believes its expectations reflected in the release are based on reasonable assumptions within the bounds of its knowledge of its business and operations; there can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ from expectations include, without limitation, the inability to pass through increases in costs and expenses for raw materials and energy; competition from other manufacturers; changes in demand for our products; the gain or loss of significant customers; fluctuations in foreign currencies and increased government regulation of our operations or our products. Additional factors that could cause Albemarle's results to differ materially from those described in the forward-looking statements can be found under "Risk Factors" in item 1A of our Annual Report for the period ended December 31, 2007.

SOURCE Albemarle Corporation 08/19/2008

CONTACT:
Media: Stephanie Dixon, 1-225-388-7904, Stephanie_Dixon@albemarle.com,
or
Rene Milligan, 1-225-388-7106, Rene_Milligan@albemarle.com;
or
Investor Relations: Sandra Rodriguez, 1-225-388-7654, Sandra_Rodriguez@albemarle.com ,
all of Albemarle Corporation Web site: http://www.albemarle.com
http://www.ethacure.com (ALB)

Share price info
Share Price
Sep 2 2010 10:32AM (ET) $42.31     0.37
Find products/services
Share Price
Advanced search
Disclaimer
Terms and Conditions